These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
209 related articles for article (PubMed ID: 9933446)
1. Inhibition of murine IgE and immediate cutaneous hypersensitivity responses to ovalbumin by the immunomodulatory agent leflunomide. Jarman ER; Kuba A; Montermann E; Bartlett RR; Reske-Kunz AB Clin Exp Immunol; 1999 Feb; 115(2):221-8. PubMed ID: 9933446 [TBL] [Abstract][Full Text] [Related]
2. Prolonged oral treatment with low doses of allergen conjugated to cholera toxin B subunit suppresses immunoglobulin E antibody responses in sensitized mice. Rask C; Holmgren J; Fredriksson M; Lindblad M; Nordström I; Sun JB; Czerkinsky C Clin Exp Allergy; 2000 Jul; 30(7):1024-32. PubMed ID: 10848926 [TBL] [Abstract][Full Text] [Related]
3. Leflunomide, a novel immunomodulating agent, prevents the development of allergic sensitization in an animal model of allergic asthma. Eber E; Uhlig T; McMenamin C; Sly PD Clin Exp Allergy; 1998 Mar; 28(3):376-84. PubMed ID: 9543089 [TBL] [Abstract][Full Text] [Related]
4. Nebulized but not parenteral IFN-gamma decreases IgE production and normalizes airways function in a murine model of allergen sensitization. Lack G; Renz H; Saloga J; Bradley KL; Loader J; Leung DY; Larsen G; Gelfand EW J Immunol; 1994 Mar; 152(5):2546-54. PubMed ID: 8133062 [TBL] [Abstract][Full Text] [Related]
5. IgE and mast cell response on intestinal allergen exposure: a murine model to study the onset of food allergy. van Halteren AG; van der Cammen MJ; Biewenga J; Savelkoul HF; Kraal G J Allergy Clin Immunol; 1997 Jan; 99(1 Pt 1):94-9. PubMed ID: 9003216 [TBL] [Abstract][Full Text] [Related]
6. Development and transfer of immediate cutaneous hypersensitivity in mice exposed to aerosolized antigen. Saloga J; Renz H; Lack G; Bradley KL; Greenstein JL; Larsen G; Gelfand EW J Clin Invest; 1993 Jan; 91(1):133-40. PubMed ID: 8423213 [TBL] [Abstract][Full Text] [Related]
7. An antagonistic IL-4 mutant prevents type I allergy in the mouse: inhibition of the IL-4/IL-13 receptor system completely abrogates humoral immune response to allergen and development of allergic symptoms in vivo. Grunewald SM; Werthmann A; Schnarr B; Klein CE; Bröcker EB; Mohrs M; Brombacher F; Sebald W; Duschl A J Immunol; 1998 Apr; 160(8):4004-9. PubMed ID: 9558109 [TBL] [Abstract][Full Text] [Related]
8. Interleukin-10-treated dendritic cells do not inhibit Th2 immune responses in ovalbumin/alum-sensitized mice. Bellinghausen I; Sudowe S; König B; Reske-Kunz AB; Knop J; Saloga J Int Arch Allergy Immunol; 2006; 141(1):61-9. PubMed ID: 16804328 [TBL] [Abstract][Full Text] [Related]
9. Oral administration of leflunomide (HWA486) results in prominent suppression of immunoglobulin E formation in a rat type 1 allergy model. Mizushima Y; Amano Y; Kitagawa H; Ogata K J Pharmacol Exp Ther; 1999 Feb; 288(2):849-57. PubMed ID: 9918599 [TBL] [Abstract][Full Text] [Related]
10. Vaccinations with T-helper type 1 directing adjuvants have different suppressive effects on the development of allergen-induced T-helper type 2 responses. Trujillo-Vargas CM; Mayer KD; Bickert T; Palmetshofer A; Grunewald S; Ramirez-Pineda JR; Polte T; Hansen G; Wohlleben G; Erb KJ Clin Exp Allergy; 2005 Aug; 35(8):1003-13. PubMed ID: 16120081 [TBL] [Abstract][Full Text] [Related]
11. Carbohydrate-based particles: a new adjuvant for allergen-specific immunotherapy. Grönlund H; Vrtala S; Wiedermann U; Dekan G; Kraft D; Valenta R; Van Hage-Hamsten M Immunology; 2002 Dec; 107(4):523-9. PubMed ID: 12460198 [TBL] [Abstract][Full Text] [Related]
12. Immune responses in the lung and local lymph node of A/J mice to intranasal sensitization and challenge with adjuvant-free ovalbumin. Farraj AK; Harkema JR; Jan TR; Kaminski NE Toxicol Pathol; 2003; 31(4):432-47. PubMed ID: 12851108 [TBL] [Abstract][Full Text] [Related]
13. Nebulized IFN-gamma inhibits the development of secondary allergic responses in mice. Lack G; Bradley KL; Hamelmann E; Renz H; Loader J; Leung DY; Larsen G; Gelfand EW J Immunol; 1996 Aug; 157(4):1432-9. PubMed ID: 8759723 [TBL] [Abstract][Full Text] [Related]
14. Allergen endotoxins induce T-cell-dependent and non-IgE-mediated nasal hypersensitivity in mice. Iwasaki N; Matsushita K; Fukuoka A; Nakahira M; Matsumoto M; Akasaki S; Yasuda K; Shimizu T; Yoshimoto T J Allergy Clin Immunol; 2017 Jan; 139(1):258-268.e10. PubMed ID: 27287257 [TBL] [Abstract][Full Text] [Related]
16. Transfer of immediate hypersensitivity and airway hyperresponsiveness by IgE-positive B cells. Lack G; Oshiba A; Bradley KL; Loader JE; Amran D; Larsen GL; Gelfand EW Am J Respir Crit Care Med; 1995 Dec; 152(6 Pt 1):1765-73. PubMed ID: 8520735 [TBL] [Abstract][Full Text] [Related]
17. Preliminary studies on the prevention of the ovalbumin-induced allergic response by Enterococcus faecalis CECT7121 in mice. Castro MS; Azpiroz MB; Molina MA; Mourelle AC; Alaniz FS; Maldonado AM; Manghi MA Int Arch Allergy Immunol; 2012; 157(1):11-20. PubMed ID: 21894024 [TBL] [Abstract][Full Text] [Related]
18. Engineered recombinant ovomucoid third domain can modulate allergenic response in Balb/c mice model. Rupa P; Mine Y Biochem Biophys Res Commun; 2006 Apr; 342(3):710-7. PubMed ID: 16494843 [TBL] [Abstract][Full Text] [Related]
19. IL-21 reduces immediate hypersensitivity reactions in mouse skin by suppressing mast cell activation or IgE production. Tamagawa-Mineoka R; Kishida T; Mazda O; Katoh N J Invest Dermatol; 2011 Jul; 131(7):1513-20. PubMed ID: 21430699 [TBL] [Abstract][Full Text] [Related]
20. In vivo kinetics of the immunoglobulin E response to allergen: bystander effect of coimmunization and relationship with anaphylaxis. Von Garnier C; Astori M; Kettner A; Dufour N; Corradin G; Spertini F Clin Exp Allergy; 2002 Mar; 32(3):401-10. PubMed ID: 11940071 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]